mecamylamine has been researched along with Urinary Bladder, Neurogenic in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, PE | 1 |
| Nanninga, JB | 1 |
1 other study available for mecamylamine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Reduction of bladder contractility after alpha-adrenergic blockade and after ganglionic blockade.
Topics: Adult; Atropine; Ganglia, Autonomic; Humans; Male; Mecamylamine; Muscle Contraction; Muscle, Smooth; | 1979 |